IMDX
Insight Molecular Diagnostics
IMDX
IMDX
47 hedge funds and large institutions have $21.1M invested in Insight Molecular Diagnostics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 52 → 47 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
47
Holding in Top 10
1
Calls
$2K
Puts
–
Top Buyers
| 1 | +$6.17M | |
| 2 | +$1.7M | |
| 3 | +$634K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$57.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.3K |
Top Sellers
| 1 | -$124K | |
| 2 | -$73.6K | |
| 3 | -$72.8K | |
| 4 |
BlackRock
New York
|
-$49.1K |
| 5 |
Millennium Management
New York
|
-$31.5K |